NPIPB13

gene
On this page

Summary

NPIPB13 (nuclear pore complex interacting protein family, member B13, HGNC:41989) is a protein-coding gene on chromosome 16p11.2, encoding Nuclear pore complex-interacting protein family member B13 (A6NJU9).

Predicted to be located in membrane.

Source: NCBI Gene 613037 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 1 total
  • MANE Select transcript: NM_001395859

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:41989
Approved symbolNPIPB13
Namenuclear pore complex interacting protein family, member B13
Location16p11.2
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000198064
Ensembl biotypeprotein_coding
Entrez613037

Gene structure

Transcript identifiers

Ensembl transcripts: 13 — 10 protein_coding, 3 nonsense_mediated_decay

ENST00000520915, ENST00000562937, ENST00000564219, ENST00000564502, ENST00000568053, ENST00000697092, ENST00000697187, ENST00000697188, ENST00000697189, ENST00000697190, ENST00000697191, ENST00000908420, ENST00000928769

RefSeq mRNA: 4 — MANE Select: NM_001395859 NM_001321892, NM_001395859, NM_001395860, NM_001395861

CCDS: CCDS81968

Canonical transcript exons

ENST00000697092 — 8 exons

ExonStartEnd
ENSE000034585053023144030231635
ENSE000034596373024545430245611
ENSE000035762813023174830231847
ENSE000035880403022730930227369
ENSE000036455303024577530248479
ENSE000036546193023545130235579
ENSE000036857043022716430227199
ENSE000039694823022289730225803

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 96.40.

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
sural nerveUBERON:001548896.40gold quality
colonic epitheliumUBERON:000039795.45gold quality
bone marrow cellCL:000209291.12gold quality
bone marrowUBERON:000237186.46gold quality
corpus callosumUBERON:000233685.96gold quality
tonsilUBERON:000237285.76gold quality
calcaneal tendonUBERON:000370184.54gold quality
primary visual cortexUBERON:000243684.12gold quality
hindlimb stylopod muscleUBERON:000425283.96gold quality
superior frontal gyrusUBERON:000266183.64gold quality
skeletal muscle tissueUBERON:000113483.44gold quality
stromal cell of endometriumCL:000225582.53gold quality
uterine cervixUBERON:000000282.05gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047381.82gold quality
right hemisphere of cerebellumUBERON:001489081.47gold quality
cerebellumUBERON:000203781.06gold quality
cerebellar cortexUBERON:000212980.88gold quality
zone of skinUBERON:000001480.83gold quality
skin of abdomenUBERON:000141680.82gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099180.69gold quality
bloodUBERON:000017880.66gold quality
cerebellar hemisphereUBERON:000224580.63gold quality
skin of legUBERON:000151180.56gold quality
liverUBERON:000210780.41gold quality
thoracic mammary glandUBERON:000520079.98gold quality
granulocyteCL:000009479.94gold quality
cortex of kidneyUBERON:000122579.93gold quality
small intestine Peyer’s patchUBERON:000345479.89gold quality
left ovaryUBERON:000211979.47gold quality
ectocervixUBERON:001224979.40gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no6.47

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

29 targeting NPIPB13, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-656-3P100.0072.152788
HSA-MIR-5692A100.0074.406850
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-6759-5P99.9966.54785
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-480399.9871.993117
HSA-MIR-6793-5P99.9765.95758
HSA-MIR-548D-3P99.8770.674362
HSA-MIR-137-3P99.8774.742401
HSA-MIR-548BB-3P99.8670.584354
HSA-MIR-548AC99.8470.774351
HSA-MIR-548H-3P99.8470.804349
HSA-MIR-548Z99.8470.804349
HSA-MIR-684499.8270.692423
HSA-MIR-3934-3P99.7665.511351
HSA-MIR-17-3P99.5566.771311
HSA-MIR-330-3P99.4169.952521
HSA-MIR-6739-3P99.2268.841843
HSA-MIR-474499.0169.911581
HSA-MIR-4742-5P98.8968.411542
HSA-MIR-4703-5P98.5370.131645
HSA-MIR-3942-5P98.5269.511517
HSA-MIR-6771-3P98.2066.53971
HSA-MIR-122-5P97.2364.921024
HSA-MIR-1288-3P96.8666.95536
HSA-MIR-316996.4067.58698
HSA-MIR-5195-5P90.8465.09287

Cross-species orthologs

0 orthologs

Paralogs (19): NPIPB12 (ENSG00000169203), NPIPB3 (ENSG00000169246), NPIPA1 (ENSG00000183426), NPIPA5 (ENSG00000183793), NPIPA6 (ENSG00000183889), NPIPB4 (ENSG00000185864), NPIPB15 (ENSG00000196436), NPIPB9 (ENSG00000196993), NPIPB6 (ENSG00000198156), NPIPA8 (ENSG00000214940), NPIPA7 (ENSG00000214967), NPIPA3 (ENSG00000224712), NPIPA9 (ENSG00000233024), NPIPB7 (ENSG00000233232), NPIPB2 (ENSG00000234719), NPIPB5 (ENSG00000243716), NPIPB11 (ENSG00000254206), NPIPA2 (ENSG00000254852), NPIPB8 (ENSG00000255524)

Protein

Protein identifiers

Nuclear pore complex-interacting protein family member B13A6NJU9 (reviewed: A6NJU9)

All UniProt accessions (10): A6NJU9, A0A1P7U241, A0A8V8TKT1, A0A8V8TKU4, A0A8V8TL61, A0A8V8TM43, A0A8V8TMC5, E5RHP9, F5GWQ4, H3BQU5

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

Similarity. Belongs to the NPIP family.

RefSeq proteins (4): NP_001308821, NP_001382788, NP_001382789, NP_001382790 (=MANE)

Domains & families (InterPro)

IDNameType
IPR009443NPIPFamily
IPR048893NPB13-like_MII_rptRepeat
IPR054697NPIP_NDomain

Pfam: PF06409, PF20885

UniProt features (16 total): compositionally biased region 12, region of interest 2, chain 1, transmembrane region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A6NJU9-F143.870.00

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 12 (showing top): chr16p11, LU_EZH2_TARGETS_DN, JOHNSTONE_PARVB_TARGETS_3_DN, MIR616_5P, MIR371B_5P, MIR373_5P, MIR6844, MIR4744, MIR3934_3P, JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP, JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN, TRAVAGLINI_LUNG_NEUTROPHIL_CELL

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (1): membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure1

Protein interactions and networks

STRING

699 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
NPIPB13KRTAP5-7Q6L8G8574
NPIPB13DEPDC4Q8N2C3447
NPIPB13KRTAP4-8Q9BYQ9444
NPIPB13MTRNR2L3P0CJ70433
NPIPB13OR1F1O43749431
NPIPB13CSTL1Q9H114359
NPIPB13CCSER2Q9H7U1350
NPIPB13SLC25A47Q6Q0C1325
NPIPB13NWD2Q9ULI1321
NPIPB13CLEC17AQ6ZS10316
NPIPB13PHYHD1Q5SRE7307
NPIPB13OSGEPL1Q9H4B0305
NPIPB13GFOD1Q9NXC2305
NPIPB13ZBTB8OSQ8IWT0305
NPIPB13MIR9-1HGQ13536294

IntAct

0 interactions, top by confidence:

ESM2 similar proteins: A0A023PXQ4, A0A0U1RQI7, A6NJU9, A6NNC1, A8MRT5, A8MUU9, C9JG80, E2RYF6, E5RHQ5, F8W0I5, O13534, O59779, P08399, P0C732, P0C785, P0DTH6, P0DW28, P13208, P15941, P21787, P24856, P39564, P51861, P87269, Q00130, Q01456, Q12444, Q13117, Q1HVI8, Q27905, Q2EEQ3, Q4ZJY7, Q4ZJZ0, Q5SDL7, Q63661, Q69577, Q6B0Y1, Q6RY98, Q6ZQT0, Q6ZRX8

Diamond homologs: A0A0B4J1W7, A6NHN6, A6NJ64, A6NJU9, A8MRT5, C9JG80, E5RHQ5, E9PIF3, E9PJ23, E9PJI5, E9PKD4, E9PQR5, F8W0I5, F8W1W9, F8WFD2, O75200, P0DM63, P0DXC3, Q92617, Q9UND3, O70490, Q08AH1, Q08AH3, Q3UNX5, Q53FZ2, Q5REV5, Q68CK6, Q6AYT9, Q6NUN0, Q6SKG1, Q8BGA8, Q8K0L3, Q91VA0, Q9BEA2, A0A179HJB8, A4YDT1, C0SPB0, P0C7M7, P39062, Q6P461

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

1 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

861 predictions. Top by Δscore:

VariantEffectΔscore
16:30231438:A:ACdonor_gain1.0000
16:30231439:C:CCdonor_gain1.0000
16:30231746:ACCTT:Adonor_gain1.0000
16:30231747:CCTTC:Cdonor_gain1.0000
16:30231750:T:Adonor_gain1.0000
16:30231845:CAC:Cacceptor_gain1.0000
16:30235443:ATACT:Adonor_loss1.0000
16:30235445:ACT:Adonor_loss1.0000
16:30235446:CTC:Cdonor_loss1.0000
16:30235448:CA:Cdonor_loss1.0000
16:30235449:A:ACdonor_gain1.0000
16:30235449:AC:Adonor_gain1.0000
16:30235449:ACC:Adonor_gain1.0000
16:30235450:C:CTdonor_gain1.0000
16:30235450:CC:Cdonor_gain1.0000
16:30235450:CCC:Cdonor_gain1.0000
16:30235450:CCCA:Cdonor_gain1.0000
16:30235450:CCCAA:Cdonor_gain1.0000
16:30235529:TCC:Tdonor_gain1.0000
16:30227307:A:ACdonor_gain0.9900
16:30227308:C:CCdonor_gain0.9900
16:30228487:T:TCacceptor_gain0.9900
16:30231635:CCT:Cacceptor_gain0.9900
16:30231637:T:Cacceptor_gain0.9900
16:30231742:CCATA:Cdonor_loss0.9900
16:30231743:CATAC:Cdonor_loss0.9900
16:30231744:ATAC:Adonor_loss0.9900
16:30231745:TA:Tdonor_loss0.9900
16:30231746:ACC:Adonor_loss0.9900
16:30231747:C:Gdonor_loss0.9900

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1005884264 (16:30231803 A>G), RS1006328338 (16:30225448 G>C,T), RS1006560765 (16:30244851 T>A), RS1007722746 (16:30246474 T>C), RS1013897487 (16:30230752 G>A), RS1015941302 (16:30232006 T>G), RS1016007980 (16:30225477 A>G,T), RS1018191438 (16:30246667 C>T), RS1030070923 (16:30245398 C>T), RS1031177352 (16:30232419 G>T), RS1031609589 (16:30246778 G>A), RS1037343252 (16:30244860 T>C,G), RS1037606735 (16:30247276 A>T), RS1043483120 (16:30230479 C>G,T), RS1044975783 (16:30230799 G>A)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

6 total (human), top 6 by PubMed support.

ChemicalActions (top 5)PubMed papers
triphenyl phosphateaffects expression1
Gallic Acidincreases expression1
Gasolineaffects cotreatment, increases abundance, increases expression1
Polycyclic Aromatic Hydrocarbonsincreases expression, affects cotreatment, increases abundance1
Asbestos, Crocidolitedecreases expression1
Particulate Matteraffects cotreatment, increases abundance, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.